Accretive Health, which provides outsourced revenue cycle management services to US hospitals, raised $120 million on Wednesday by offering 10 million shares at $12, 20% below the midpoint of the $14 to $16 proposed range. The company had initially planned to offer 13.3 million shares. Accretive Health is expected to begin trading Thursday on the NYSE under the symbol AH. Goldman, Sachs & Co., Credit Suisse, and J.P. Morgan acted as lead managers on the deal.
